Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years. Now, the Sandia materials chemist and his long-term collaborators at Imagion Biosystems will use these magnetic nanoparticles for their first breast cancer clinical trial later this year.
Continue Reading Magnetic nanoparticles leap from lab bench to breast cancer clinical trials